What are the uses of Pyridostigmine (Mestinon)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pyridostigmine is primarily used to treat myasthenia gravis, with a recommended dosing of 30-600 mg daily, and may also be used in the management of immune-related adverse events, particularly those with myasthenic symptoms, as stated in the 2022 ESMO clinical practice guideline 1.

Uses of Pyridostigmine

  • Treatment of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue
  • Management of immune-related adverse events, particularly those with myasthenic symptoms
  • Pretreatment against nerve agent poisoning in military settings
  • Off-label uses for treating postural orthostatic tachycardia syndrome (POTS) and managing some autonomic disorders

Dosage and Administration

  • Typical dosing for adults with myasthenia gravis: 30-60 mg orally every 3-4 hours while awake, adjusted based on symptom control
  • Dosing for immune-related adverse events: 30 mg orally up to 600 mg daily, as needed
  • Intravenous application: 1 mg i.v. corresponds to 30 mg oral pyridostigmine

Side Effects and Monitoring

  • Common side effects: gastrointestinal symptoms, increased salivation and sweating
  • Patients should be monitored for cholinergic crisis, which can occur with overdosage and presents with severe muscle weakness, respiratory difficulties, and excessive secretions
  • The medication should be taken consistently to maintain therapeutic levels and may require dose adjustments based on individual response and tolerance

Recent Guidelines and Recommendations

  • The 2022 ESMO clinical practice guideline recommends pyridostigmine as a treatment option for immune-related adverse events with myasthenic symptoms 1
  • The 2024 adult strabismus preferred practice pattern recommends pyridostigmine as the first line of treatment for myasthenia gravis, but notes that about half of patients with strabismus-associated myasthenia show minimal response 1

From the FDA Drug Label

Pyridostigmine bromide is useful in the treatment of myasthenia gravis. The main use of pyridostigmine is in the treatment of myasthenia gravis 2.

  • Key uses: treatment of myasthenia gravis It works by inhibiting the destruction of acetylcholine by cholinesterase, permitting freer transmission of nerve impulses across the neuromuscular junction 2.

From the Research

Pyridostigmine Uses

  • Pyridostigmine is used in the symptomatic treatment of myasthenia gravis (MG) 3, 4, 5, 6, 7
  • It is an anticholinesterase agent that has been used for over 50 years to treat MG 6
  • Pyridostigmine is suitable as a long-term treatment in patients with generalized non-progressive milder disease, and as an adjunctive therapy in patients with severe disease who are also receiving immunotherapy 6

Efficacy and Side Effects

  • Patients reported a median effectiveness of 60 and net benefit of 65 when using pyridostigmine 3
  • Common side effects of pyridostigmine include flatulence, urinary urgency, muscle cramps, blurred vision, and hyperhidrosis 3
  • Diarrhea, abdominal cramps, and muscle twitching are also reported as reasons to discontinue pyridostigmine 3

Administration and Dosage

  • The sustained-release dosage form of pyridostigmine (SR-Pyr) can reduce the number of daily doses and improve the total quantified myasthenia gravis (QMG) score 5
  • Continuing pyridostigmine till the day of surgery or omitting it on the night before surgery can provide variable results with regards to the effect of vecuronium 4

Historical Aspects

  • Pyridostigmine bromide was unsuccessful in its "pioneering trials" to treat a series of MG patients, but it has become an indispensable anticholinesterase agent used worldwide to treat patients with MG 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.